SLC25A38 and cancer: Since SLC25A38 acts as a transporter of glycine across mitochondrial inner membrane, we hypothesize that knock-down of SLC25A38 may inhibit the transport of glycine to cytoplasm, and the accumulation of glycine in mitochondria may lead to the increase of glycine metabolism, thus facilitate the maintenance of the malignant properties of cancer cells.